Literature DB >> 20224440

Epstein-Barr virus-associated intracranial leiomyosarcoma in an HIV-positive adolescent.

Sweta Gupta1, Peter L Havens, James F Southern, Selim Y Firat, Sachin S Jogal.   

Abstract

SUMMARY: A 17-year-old African American female with human immunodeficiency virus infection presented with an unresectable intracranial neoplasm with mass effect upon the brainstem. Stereotactic biopsy revealed an Epstein-Barr virus (EBV)-associated leiomyosarcoma. Radiation therapy and gemcitabine were used to shrink the mass with the aim to make it surgically resectable. Prolonged neutropenia and recurrent skin infections led to the discontinuation of gemcitabine. The mass stabilized after radiation therapy and has decreased in size in 15 months of follow-up. EBV has been demonstrated in most smooth muscle tumors associated with acquired immunodeficiency syndrome and other immunocompromised states. This is the first documented case of an EBV-positive intracranial leiomyosarcoma in a pediatric human immunodeficiency virus patient.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224440     DOI: 10.1097/MPH.0b013e3181c80bf3

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  12 in total

1.  Primary intracranial leiomyosarcoma of the torcular Herophili associated with Fanconi anemia and allogenic stem cell transplantation.

Authors:  Michèle Aumüller; Karl-Walter Sykora; Christian Hartmann; Elvis J Hermann; Joachim K Krauss
Journal:  Childs Nerv Syst       Date:  2014-04-22       Impact factor: 1.475

2.  Primary Leiomyosarcoma of the Calvarium with Intracranial Extension: a Case Report.

Authors:  Amade Bregy; Jaims Lim; Robert Lohman; John Kane; Dheerendra Prasad; Jingxin Qiu; Robert A Fenstermaker
Journal:  Indian J Surg Oncol       Date:  2020-07-01

3.  Contemporary management and classification of hepatic leiomyosarcoma.

Authors:  Mazin O Hamed; Keith J Roberts; William Merchant; J Peter A Lodge
Journal:  HPB (Oxford)       Date:  2014-11-24       Impact factor: 3.647

4.  Epstein-Barr virus-associated smooth muscle tumors in immunocompromised patients: Six case reports.

Authors:  Afshin A Khan; Bassam N Estfan; Anirudh Yalamanchali; Djibril Niang; Erica C Savage; Clifton G Fulmer; Hailey L Gosnell; Jamak Modaresi Esfeh
Journal:  World J Clin Oncol       Date:  2022-06-24

5.  Surgical management and long-term outcomes of primary intracranial leiomyosarcoma: a case series and review of literature.

Authors:  Gui-Jun Zhang; Jian-Cong Weng; Xu-Lei Huo; Jun-Peng Ma; Bo Wang; Liang Wang; Huan Li; Da Li; Jun-Ting Zhang; Zhen Wu
Journal:  Neurosurg Rev       Date:  2020-10-24       Impact factor: 3.042

Review 6.  Primary intracranial smooth muscle tumor associated with Epstein-Barr virus in immunosuppressed children: two cases report and review of literature.

Authors:  Maximiliano Paez-Nova; Karem Andaur; Ezequiel García-Ballestas; Diego Bustos-Salazar; Luis Rafael Moscote-Salazar; Osvaldo Koller; Sergio Valenzuela
Journal:  Childs Nerv Syst       Date:  2021-04-22       Impact factor: 1.475

Review 7.  Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review.

Authors:  Kishor Bhatia; Meredith S Shiels; Alexandra Berg; Eric A Engels
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.915

8.  AIDS-Related EBV-Associated Smooth Muscle Tumors: A Review of 64 Published Cases.

Authors:  Bibianna Purgina; Uma N M Rao; Markku Miettinen; Liron Pantanowitz
Journal:  Patholog Res Int       Date:  2011-03-10

9.  Primary intracranial leiomyosarcoma in an immunocompetent patient: Case report with emphasis on imaging features.

Authors:  Xiu-Li Li; Jing Ren; Run-Ning Niu; Xiao Jiang; Guo-Hui Xu; Peng Zhou; Zhu-Zhong Cheng
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

10.  Juvenile Idiopathic Arthritis With Epstein-Barr Virus-Associated Smooth Muscle Tumor in a 6-Year-Old Girl: A Rare Case Report.

Authors:  Zhijuan Kang; Juan Xu; Zhihui Li
Journal:  Front Pediatr       Date:  2021-06-18       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.